We don't need to do a reverse split to up-list.
Post# of 148294
Please refer to https://listingcenter.nasdaq.com/assets/initialguide.pdf
In Nasdaq there are three tiers, we have talked about this before:
The Nasdaq Global Select Market, The Nasdaq Global Market and The Nasdaq Capital Market .
Under the latter there are three standards in order to comply with the Financial and Liquidity Requirements (one has to qualify under only one to list).
We currently qualify for two of them : Equity Standard Market Value of Listed Securities Standard . We don't for the Net Income Standard (would need $750.000 net income from Continuing Operations in the latest fiscal year or in two of the last three fiscal years).
Depending which one we decide to go for the closing price needs to be $3 or $2 (take your pick ) . But we need to comply with:
Net tangible assets of $2 million and a 3 year operating history, in addition to satisfying the other financial and liquidity requirements listed above. Also:
Quote:
In addition to the above requirements, if the security is trading in the U.S. over-the-counter market as of the date of application, the security must have a minimum average daily trading volume of 2,000 shares (including trading volume of the underlying security on the primary market with respect to an ADR), over the 30 trading day period prior to listing, with trading occurring on more than half of those 30 days, unless such security is listed on the Exchange in connection with a firm commitment underwritten public offering of at least $4 million.
Which we do comply with.
So, there is no need to reverse split or do any gymnastics. Nader should be really looking very hard at up-listing ASAP. This will propel CytoDyn really fast !!! (Institucional ownership).